期刊文献+

人胰岛素样生长因子I基因增强组织工程修复全层半月板缺损

Repair of full-thickness meniscal defect with human insulin-like growth factor I gene-enhanced tissue engineering
原文传递
导出
摘要 目的建立全层无血运区半月板缺损模型,观察人胰岛素样生长因子I(humanin—sul in—like growth factorI,hIGF—I)基因修饰骨髓间充质干细胞(bone—marrow mesenchymal stem cells,BMSCs)复合可注射藻酸钙凝胶修复半月板缺损的效果。方法制造成年山羊半月板前角无血运区全层缺损模型。实验分为四组,即基因增强组织工程(gene—enhancedtissueengineer-ing,GETE)组(GETE组):用hIGF—I基因转染的BMSCs复合可注射藻酸钙凝胶修复半月板缺损;BMSCs组:用BMSCs复合藻酸钙凝胶修复缺损;空载体组:用藻酸钙凝胶空载体修复缺损;对照组:缺损旷置,不做任何修复。术后4,8,16周时相点行大体观察;光镜、电镜观察修复组织变化;测定修复组织中蛋白聚糖含量。结果GETE组修复半月板缺损在4—16周效果逐渐改善,缺损完全被修复组织填充,色白质韧,结合紧密,与正常半月板组织相似,大体观察优于其他各组;光镜下可见细胞随凝胶纤维排列分布,载体纤维间隙大多为细胞分泌基质所充填,细胞排列密集,基质分布均匀;扫描电镜观察到纤维排列规整紧密,纤维间缝隙为致密的细胞外基质填充;修复组织中蛋白聚糖含量较高,但与正常半月板仍有差异。结论转染hIGF—I基因的BMSCs复合可注射藻酸钙凝胶可改善全层半月板缺损的修复效果。 Objective To establish a model of full-thickness avascular meniscal defect to assess outcome of bone-marrow mesenchymal stem cells (BMSCs) modified with human insulin-like growth fac- tor I ( hIGF- I ) gene and compounded with injectable calcium alginate gel in repair of meniscal defect. Methods Models of full-thickness defect were created in the anterior corner of meniscus in goats, an ar- ea lacking of blood supply. The trial categorized the models to four groups : gene-ehanced tissue engineer- ing (GETE) group (hIGF-[ transfected BMSCs were mixed with calcium alginate gel), BMSCs group (BMSCs were mixed with calcium alginate gel) , empty group (calcium alginate gel was used alone) and control group (the defect was excluded from repair). Maeroscopy was done at 4, 8, and 16 weeks after operation. Variation of repair tissue was observed by light and scanning electric microscopy and aggrecan in repair tissue was determined as well. Results Meniscal defect was on the mend at 4-16 weeks after operation in GETE group, with the defect area being thoroughly filled with the white, elastic and tight re- pair tissue similar to normal meniscal tissue. Macroscopic examination showed a better result in GETE group than that in other groups. Light microscopy showed that repair tissue which was mainly fibrochon- drocytes was arranged in line with calcium alginate fibers and that space between the fibers was mostly crammed with the matrix secreted by those cells. At the same time, those cells were tightly arranged and the matrix secreted by those cells was equally distributed according to light microscopy. Electroscopy dem- onstrated neat and tight arrangement of fibers and tight extracellular matrix in fiber spar in GETE group.Aggrecan concentration in GETE group was relatively higher than in other groups, but still had difference from the normal meniscus. Conclusion hIGF-I gene-transfected BMSCs combined with injectable calcium alginate gel can improve the effect in repair of full-thickness meniscal defect.
出处 《中华创伤杂志》 CAS CSCD 北大核心 2013年第4期359-363,共5页 Chinese Journal of Trauma
基金 国家自然科学基金资助项目(81171774,81272056)
关键词 半月板 胫骨 基因 组织工程 胰岛素样生长因子I Menisci, tibial Genes Tissue engineering Insulin-like growth factor I
  • 相关文献

参考文献11

  • 1李卿,刘伟,夏万尧,崔磊,曹谊林.爱茜蓝法检测组织工程化软骨及软骨细胞中蛋白聚糖的含量[J].中华实验外科杂志,2003,20(1):89-89. 被引量:9
  • 2Englund M, Roemer FW, Hayashi D, et al. Meniscus pathology, osteoarthritis and the treatment controversy. Nat Rev Rheumatol, 2012, 8(7) :412 -419.
  • 3Anz AW, Rodkey WG. Biological enhancement of meniscus repair and replacement. Sports Med Arthrosc, 2012, 20 (2) :115 J 120.
  • 4Scordino LE, Deberardino TM. Biologic enhancement of meniscus repair. Clin Sports Med, 2012, 31 ( 1 ) :91 - 100.
  • 5Maier D, Braeun K, Steinhauser E, et al. In vitro analysis of an allogenic scaffold for tissue - engineered meniscus replacement. J Orthop Res, 2007, 25 (12) : 1598 - 1608.
  • 6Stone KR, Rodkey WG, Webber R, et al. Meniscal regeneration with copolymeric collagen scaffolds. In vitro and in vivo studies e- valuated clinically, histologically and biochemically. Am J Sports Med, 1992, 20(2) :104 -111.
  • 7Stone KR, Steadman JR, Rodkey WG, et al. Regeneration of me- niscal cartilage with use of a collagen scaffold. Analysis of prelimi- nary data. J Bone Joint Surg ( Am), 1997, 79 (12) : 1770 - 1777.
  • 8Pereira H, Frias AM, 01iveira JM, et al. Tissue engineering and regenerative medicine strategies in meniscus lesions. Arthroscopy, 2011, 27(12) :1706 -1719.
  • 9Bhargava MM, Attia ET, Murrell GA, et al. The effect of cyto- kines on the proliferation and migration of bovine meniscal cells. Am J Sports Med, 1999, 27(5) :636 -643.
  • 10Goto I-I, Shuler FD, Lamsam C, et al. Transfer of LacZ marker gene to the meniscus. J Bone Joint Surg (Am), 1999, 81 (7) : 918 - 925.

二级参考文献9

  • 1Jansen M, Van Schaik FMA, Richer AT, et al. Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature, 1983, 306:609-611.
  • 2Lazowski DA, Fraher LJ, Iiodsman A, et al. Regional variation of insulin growth factor-I gene expression in mature rat bone and cartilage. Bone, 1994,15:563-576.
  • 3Kurland ES, Rosen CJ, Cosman F, et al. Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab, 1997,82:2799-2805.
  • 4Trippel SB, Corvol MT, Dumontier MF, et al. Effect of somatomedin-C/insulin-like growth factor I and growth hormone on cultured growth plate and articular chondrocytes. Pediatr Res, 1989,25:76-82.
  • 5Owen M. Marrow stromal stem cells. J Cell Sci Suppl, 1988,10:63-67.
  • 6Olmsted EA, Blum JS, Rill D, et al. Adenovirus-mediated BMP2 expression in human bone marrow stromal cells. J Cell Biochem,2001, 82:11-21.
  • 7Mi Z, Chivizzani SC, Lechman ER, et al. Adenovirus-mediated gene transfer of insulin-like growth factor-I stimulates proteoglycan synthesis in rabbit joints. Arthritis Rheum, 2000,43:2563-2570.
  • 8Evans CH, Robbins PD, Ghivizzani SC, et al. Clinical trial to assess the safety, feasibility and efficiency of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther,1996,7:1261-1264.
  • 9J. E. Scott. Histochemistry of Alcian blue[J] 1972,Histochemie(2):215~234

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部